[Form 4] AST SpaceMobile, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Andrew M. Johnson, who serves as CFO and CLO and is reported as a director of AST SpaceMobile, Inc. (ASTS), disclosed an open-market sale of Class A common stock on 08/26/2025. The filing reports 20,000 shares sold at a weighted average price of $52.48 (individual sale prices ranged from $52.46 to $52.56). After the sale, the reporting person beneficially owns 397,485 shares. The Form 4 is signed by the reporting person and includes a footnote offering to provide the exact number of shares sold at each price within the disclosed range.
Positive
- Timely disclosure of the insider sale on Form 4 by an officer and director
- Weighted average price and price range are provided, with an offer to disclose per-trade quantities on request, enhancing transparency
- Reporting person retains substantial ownership after the transaction (397,485 shares)
Negative
- Officer sold 20,000 shares, which reduces insider holdings and could be interpreted by some investors as a negative signal
- No indication in the filing of a Rule 10b5-1 plan or the reasons for the sale, leaving motive unclear
Insights
TL;DR: Insider sale disclosed by CFO/CLO reduces his stake; filing appears compliant and transparent.
The Form 4 documents an open-market disposition by a named officer and director on 08/26/2025. The report provides the weighted average selling price and a footnote committing to disclose per-price quantities if requested, which supports regulatory transparency. The filing shows continued substantial ownership post-sale, suggesting the transaction was not a full divestiture. From a governance perspective, timely Form 4 disclosure is appropriate and helps maintain market transparency.
TL;DR: A modest-sized sale of 20,000 shares at ~$52.48 each; the transaction is routine and not by itself material.
The sale reduced the reporting person's beneficial holdings to 397,485 shares. The weighted average sale price is disclosed with a narrow price range, and the filer offers to provide detailed per-trade counts on request. There is no indication in the Form 4 of derivative transactions or plans such as Rule 10b5-1; the form is a straightforward Section 16 disclosure. Absent other company news, this single transaction is unlikely to be materially impactful to ASTS valuation on its own.